Journal Papers, Abstracts, and Commentaries
| |
Impact of Antiretroviral Regimens on CSF Viral Escape in a
Prospective Multicohort Study of ART-Experienced HIV-1
Infected Adults in the United States.
Mukerji SS, Misra
V, Lorenz DR,
et al
Clin Infect Dis.
2018 Apr 3.
Abstract
FULL-TEXT ARTICLE
Virologic outcome among patients receiving antiretroviral
therapy at five hospitals in Haiti.
Jean Louis F, Buteau J, François K,
LoS One.
2018 Jan 30;13
Paper
Immunological and virological response to antiretroviral
treatment in migrant and native men and women in Western
Europe; is benefit equal for all?
Migrant Health Working Group for the Collaboration of
Observational HIV Epidemiological Research in Europe
(COHERE) in EuroCoord.
HIV Med.
2017 Jul 25
Abstract
HIV viral load suppression in adults and
children receiving antiretroviral therapy - results from the
IeDEA collaboration.
Jiamsakul
A, Kariminia A, Althoff KN, et al
J Acquir Immune Defic Syndr.
2017
Jul 8.
Abstract
Virologic failure is uncommon after treatment initiation
during acute HIV infection.
Crowell TA,
Phanuphak N, Pinyakorn S, et al
AIDS. 2016 May
9.
Abstract
Longitudinal analysis of the associations between
antiretroviral therapy, viraemia and immunosuppression with
lipid levels: the D:A:D study
Kamara DA, Smith C, Ryom L, Reiss P, et al
Antivir Ther.
2016 Apr 26.
Abstract
The Contribution of Missed Clinic Visits to
Disparities in HIV Viral Load Outcomes.
Zinski A, Westfall AO, Gardner LI, et al
Am J Public Health.
2015 Aug 13:e1-e8
Abstract
Extraordinary heterogeneity of virological outcomes in
Patients Receiving HAART and Monitored with the World Health
Organization (WHO) Public Health Approach in sub-Saharan
Africa and south-east Asia.
Aghokeng AF, Monleau M, Eymard-Duvernay S, et al
Clin Infect Dis. 2013 Sep 27.
Abstract
FULL-TEXT ARTICLE
Timeliness of Clinic Attendance Is a Good Predictor of
Virological Response and Resistance to Antiretroviral Drugs
in HIV-Infected Patients.
Bastard M, Pinoges L, Balkan S,
PLoS One.
2012;7(11):e49091.
Paper
Improved Virological Outcome in White
Patients Infected With HIV-1 Non-B Subtypes Compared to
Subtype B.
Scherrer AU, Ledergerber B, von Wyl V, et al
Clin Infect Dis.
2011 Oct 13.
Abstract
Food Insecurity is Associated with Poor
Virologic Response among HIV-Infected Patients
Receiving Antiretroviral Medications.
Wang EA, McGinnis KA, Fiellin DA, et al
J Gen Intern Med.
2011 May 15.
Abstract
Virologic and immunologic response to HAART, by age and
regimen class.
Althoff KN, Justice AC, Gange SJ, et al
AIDS. 2010 Sep
8.
Abstract |
The Effect of HAART on HIV RNA Trajectory Among Treatment-naïve Men and
Women:
A Segmental Bernoulli/Lognormal Random Effects Model With Left Censoring.
Chu H, Gange SJ, Li X, et al
Epidemiology. 2010
Apr 7.
Abstract |
Treatment response in acute/early infection versus advanced AIDS: equivalent
first and second
phases of HIV RNA decline.
Kilby JM, Lee HY, Hazelwood JD, et al
AIDS. 2008 May 11;22(8):957-62.
Abstract
|
Long-Term CD4+ T-Cell Response to Highly Active Antiretroviral Therapy
According to
Baseline
CD4+ T-Cell Count.
Garcia F, De Lazzari E, Plana M, et al J
Acquir Immune Defic Syndr. 2004 Jun
1;36(2):702-713.
Abstract
CD4 T cell recovery is slower in patients experiencing viral load rebounds
during
HAART.
Scott-Algara D, Aboulker JP, Durier C, et al.
Clin Exp Immunol 2001
Nov;126(2):295-303
Abstract
|
| |
HIV viral load response to antiretroviral therapy according to the baseline
CD4
cell
count
and viral load.
Phillips AN, Staszewski S, Weber R, et al
JAMA. 2001 Nov 28;286(20):2560-7.
Abstract |
Conference Reports, Abstracts, and
Posters
Journal Papers, Abstracts, and Commentaries
|
Magnitude of Virologic Blips Is Associated With a Higher Risk for
Virologic Rebound in HIV-Infected
Individuals: A Recurrent Events Analysis.
Grennan JT, Loutfy MR,
Su D, et al
J Infect Dis.
2012 Apr;205(8):1230-1238
Abstract
Plasma HIV-1 RNA Detection Below 50 Copies/mL and
Risk of Virologic Rebound in Patients Receiving
Highly Active Antiretroviral Therapy.
Doyle T, Smith C, Vitiello P, et al
Clin Infect Dis. 2012 Jan 11.
Abstract
Virological rebound after suppression on highly active antiretroviral
therapy.
Mocroft A, Ruiz L, Reiss P
AIDS. 2003 Aug 15;17(12):1741-1751.
Abstract
|
| |
Consecutive rebounds in plasma viral load are associated with virological
failure at
52 weeks
among HIV-infected patients.
Raboud JM, Rae S, Woods R, et al
AIDS. 2002 Aug 16;16(12):1627-32.
Abstract
|
| |
Raised viral load in patients with viral suppression on highly active
antiretroviral therapy:
transient increase or treatment failure?
Moore AL, Youle M, Lipman M, et al.
AIDS. 2002 Mar 8;16(4):615-8.
Abstract |
Clinical progression and virological failure on highly active antiretroviral
therapy in HIV-1
patients: a prospective cohort study. Swiss HIV Cohort Study.
Ledergerber B, Egger M, Opravil M, et al.
Lancet. 1999 Mar 13;353(9156):863-8.
Abstract
|
General
Reports
HAART
Main Page
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
